Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group

Affiliations

• ¹ ANRS, Clinical Research Safety Department, France; INSERM, Clinical Research Safety Department, France.
• ² Oslo University Hospital, Department of Rheumatology, Dermatology and Infectious Diseases, Norway.
• ³ Oslo University Hospital, Department of Research Support for Clinical Trials, Norway.
• ⁴ ECRIN, Director General, France.
• ⁵ Inserm Transfert SA, Department Collaborative Research Funding, France.
• ⁶ Centro Hospitalar Universitário de São João, Department of Critical Care Medicine, Portugal.
• ⁷ Erasmus Hospital, Infectious Diseases, Belgium.
• ⁸ Hospices Civils de Lyon, Service de Maladies Infectieuses et Tropicales, France.
• ⁹ La Paz University Hospital, Infectious Diseases Unit, Spain.
• ¹⁰ Oslo University Hospital, Department of Immunology, Norway.
• ¹¹ Norwegian Institute of Public Health, Department of Assessment of Interventions, Norway.
• ¹² University of Verona, Division of Infectious Diseases, University of Verona, Diagnostic and Public Health, Italy.
• ¹³ Centre Hospitalier de Luxembourg, Maladies Infectieuses, Luxembourg.
• ¹⁴ Paracelsus Medical University Salzburg, Laboratory of Immunological and Molecular Cancer Research, Austria.
• ¹⁵ National and Kapodistrian University of Athens - Faculty of Medicine, 4th Department of Internal Medicine, Greece.
• ¹⁶ University Hospital Basel, Clinical Research, Switzerland.
• ¹⁷ INSERM, Pôle de Recherche Clinique, France.
• ¹⁸ Hôpital Bichat Claude-Bernard, Epidémiologie, biostatistique et recherche clinique, France.
• ¹⁹ University College Cork, Clinical Research, Ireland.
• ²⁰ INSERM, Project Manager Clinical Microbiology and Infection, France.
• ²¹ ANRS, Soutiens structurants à la recherche Gestion budgétaire et sites cliniques, France.
• ²² INSERM, Project Manager, France.
• ²³ Sorbonne Université, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), France.
• ²⁴ Norwegian Institute of Public Health, Division of Infectious Disease Control, Norway.
• ²⁵ INSERM, IAME, Hôpital Bichat - Claude-Bernard, Infectious Diseases Department, France. Electronic address: yazdan.yazdanpanah@inserm.fr.